Aclaris Therapeutics, Inc.
A clinical-stage biopharma developing novel drugs for immuno-inflammatory diseases.
ACRS | NDAQ
Overview
Corporate Details
- ISIN(s):
- US00461U1051
- LEI:
- Country:
- United States of America
- Address:
- 701 LEE ROAD, 19087 WAYNE
- Website:
- https://www.aclaristx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases. The company aims to translate scientific discovery into therapeutic solutions for underserved conditions. Aclaris leverages its core expertise in drug discovery, development, and kinase inhibition to advance a pipeline of innovative small and large molecule drugs designed to address significant unmet medical needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Aclaris Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Aclaris Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Aclaris Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
